Allergan breaks ground on $200 million Waco facility expansion
Provides manufacturing capabilities for more than 40 different product formulations.
BMS's Opdivo receives Breakthrough Therapy Designation from FDA for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck
Designation signals the urgent need for new treatment approaches in recurrent or metastatic squamous cell carcinoma of the head and neck after platinum based therapy.
Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals
Brings more than three decades of leadership and operations experience in healthcare.
Chantix/Champix results from the largest global clinical trial of smoking cessation medicines published in The Lancet
uthors conclude no significant increase in serious neuropsychiatric adverse events with Chantix/Champix relative to placebo or nicotine patch.
Innova Biosciences expands UK facility and increases laboratory space
The move comes in response to increasing demand for its products and services.
GSK opens new state-of-the-art respiratory manufacturing facility in Ware, UK
Facility needed to meet growing export demand for GSK respiratory medicines.
Novo Nordisk to invest more than 100 million euro in production plants in Chartres, France
The expansions will help the company to meet the increasing worldwide demand for its diabetes medicines.
Allergan acquires topical dermatology company Topokine Therapeutics adding non-invasive fat reduction development program
Adds global rights to XAF5, potential first-in-class topical treatment for steatoblepharon, or undereye bags.
New webinar: optimizing analytics for biosimilars
How providing comprehensive data can accelerate drug development.